Form 4: Stryker Director Sherilyn McCoy Receives RSU Grant
Statement of Changes in Beneficial Ownership
Director Sherilyn S. McCoy was granted 762 restricted stock units by Stryker Corporation, with a deferred settlement date of May 1, 2031.
Summary
- Director Sherilyn S. McCoy received a grant of 762 Restricted Stock Units (RSUs) on May 6, 2026.
- Each RSU represents a contingent right to receive one share of Stryker Common Stock.
- The RSUs vest on the earlier of the 2027 Annual Meeting of Shareholders or May 6, 2027.
- The reporting person has elected to defer receipt of the underlying shares until May 1, 2031.
- Following this transaction, the reporting person holds a total of 7,190 shares of Stryker Common Stock.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation that has no material impact on the company's financial outlook.
Positives
- The grant aligns the director's long-term interests with those of shareholders through equity-based compensation.
Negatives
- None identified; this is a standard equity compensation disclosure for a corporate director.
Risks
- None identified; this filing relates to routine director compensation.
Future Outlook
The filing does not provide forward-looking financial guidance for the company, as it is a disclosure of director equity compensation.
Industry Context
StockSavvy.ai notes that this filing is a routine disclosure of director compensation within the medical technology sector, reflecting standard corporate governance practices for equity alignment.
Comparison to Industry Standards
- The use of RSU grants for board members is a standard practice among S&P 500 companies to ensure long-term alignment with shareholder interests.
- The deferral of share receipt is a common tax and wealth management strategy utilized by corporate directors.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Updated Power of Attorney filed for SEC reporting purposes. | 2025-08-20 | Administrative update to facilitate regulatory compliance. |
Stakeholder Impact
- Minimal impact on stakeholders; reflects standard director compensation.
Next Steps
- Vesting of the RSU grant on or before May 6, 2027.
- Settlement of the deferred shares on May 1, 2031.
Key Dates
| Date | Description |
|---|---|
| 2025-08-20 | Date of Power of Attorney execution. |
| 2026-05-06 | Date of RSU grant transaction. |
| 2027-05-06 | Vesting date for the RSU grant (or earlier at the 2027 Annual Meeting). |
| 2031-05-01 | Deferred settlement date for the shares. |
Keywords
Stryker, SYK, Director, Equity Compensation, Restricted Stock Units, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.